Project Description:

Hospital-acquired pressure injuries (HAPI), notably medical device-related pressure injuries (MDRPIs), pose significant challenges in healthcare, especially in ICUs. NGTs, essential in prolonged medical procedures, often lead to nasal pressure injuries, exacerbating patient discomfort and prolonging hospital stays. Current protocols focus on catheter placement rather than addressing root causes. The NasoGuard ComfortShield addresses this gap by mitigating risks associated with nasogastric tubes. Its hypoallergenic padding ensures a secure yet gentle fit, preventing pressure injuries. Unique features include a breathable gel material with perforations for comfort without compromising protection. A thermochromic pigment indicates temperature changes, signaling potential injuries, while a perfusion probe monitors tissue health, enhancing preventative care. This breakthrough device promises increased patient comfort and reduced pressure injury rates, particularly in ICUs where patients are most vulnerable. Commercially, it offers compelling licensing opportunities for hospitals and medical device firms, delivering added value and potential cost savings. With an estimated 2.5 million HAPI cases annually in the U.S., the market size for this device is substantial. Its innovative design and materials make it a strong candidate for patenting, ensuring market exclusivity and competitive advantage.